Matthew Buten, Chief Financial Officer at Biohaven (NYSE:BHVN), reported a large insider buy on October 6, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Buten purchased 22,727 shares of Biohaven. The total transaction amounted to $499,994.
Biohaven shares are trading up 0.46% at $24.26 at the time of this writing on Friday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to make an investing decision, however, they ...